Clinical Trial Update: A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LEO 80190 ointment with hydrocortisone ointment, both applied once daily for psoriasis vulgaris on the face and intertriginous areas; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Hydrocortisone ointment (hydrocortisone)
• LEO 80190 ointment

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2019-01-15